Medical Affairs Excellence Services

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
INCLUDED RESEARCH

The dynamic bio-pharmaceutical and medical device companies are accelerating their medical affairs function scope beyond a traditional support function. The function manages strategic responsibilities bridging research as well as clinical development, its scientific publications strategy and utilizes health outcomes, biostatistics, necessary medical education and other medical services.

The medical affairs function enhances a company’s scientific reputation and complements the work of Research & Development. It also provides physicians, key opinion leaders (KOLs), legal-regulatory agencies, professional groups and healthcare professionals with medical and scientific information and education on the value and proper use of a company’s products, therapies, devices, technology and diagnostics.

These excellence services, provided by Best Practices, LLC, allow executives to gain strategic insight and successful approaches for competitive performance in medical affairs functions. The study lays key focus on gauging market attention, utilizing health outcomes, scientific publications strategy, educating physicians, key opinion leaders, patient advocacy and clinical developments.

The Medical Affairs Excellence Services is offers many options to the Medical Affairs executives seeking strategic insight and successful approaches.� For more information and to create the right Excellence Services offering to meet your needs, please contact James Drake at (603) 410-3929 to learn more and to discuss pricing options.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Manufacturing; Consumer Products; Chemical; Biopharmaceutical; Financial Services; Technology; Clinical Research; Laboratories; Orthopaedics

Companies Profiled:
Abbott; Abbott Animal Health; Abbvie; Acorda Therapeutics; Akron Molecules; Algeta; Alkem Laboratories; Amgen; Amylin; Astellas; AstraZeneca; Baxter; Baxter Healthcare; Bayer; Bayer Healthcare; BARD; Becton Dickinson; Biogen Idec; BMS; Boehringer Ingelheim; Boston Scientific; Bracco Diagnostics; Covidien; Cubist; Cubist Pharmaceuticals; Daiichi-Sankyo; Eisai; Endo; Endo Health Solutions; Esteve; Ethicon; Ethicon Endo-Surgery Inc.; Ferring Pharmaceuticals; Forest; Fresenius; Genentech; Gilead; Gilead Sciences; GlaxoSmithKline; Grunenthal; Guerbet; Insight Pharmaceuticals; Ipsen; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Kadmon Pharmaceuticals; LEO Pharma; LifeCell; Mallinckrodt; MAP Pharmaceuticals; Medivation; MedImmune; Medrad; Medtronic; Medunik; Merck Serono; Merck & Co.; Methapharm; MSD Pharma; Mylan; Novartis; Novo Nordisk; Onyx; Onyx Pharmaceuticals; Orthofix; Pacira; Peloton; Pfizer; Philips Healthcare; Ranbaxy; Regeneron; Roche; Sanofi; Sanofi Pasteur; Shire; Shire HGT; Smith & Nephew; Stallergenes; Terumo Corporation; Teva; UCB; UCB Pharma; United Therapeutics; Upsher-Smith Labs; Valeant; ViiV Healthcare; ViroPharma; Xanodyne; Xanodyne Pharmaceuticals; Zimmer

Who Can Benefit From These Services?

These services provide valuable material for executives of the pharmaceutical organization to ensure superior execution and implementation of medical affairs strategy and drive operational efficiency. Executives will find numerous resource-related issues addressed, while the execution level managers will be able to create roadmaps and plans for accomplishing their objectives in key areas.

These services are geared for pharmaceutical executives with responsibilities in the areas of:

Medical Affairs structuring and funding
Post-marketing surveillance for adverse events
Thought leaders relationships
Pharmaceutical speaker programs - training and development
Scientific Publications strategy
Medical Science Liaisons
Key Opinion Leader Relationships
Collaborating with patient advocacy groups
New Product Planning
Webinars for enhancing key opinion leader relationships
Educating the marketplace for new Product launches – oncology

This bundle combines all of the individual research listed below into one easy-to-purchase transaction. Read individual research abstracts by clicking the titles. Return to this page to add the bundle to your cart.

•

Medical Affairs Excellence Services

ID: OPS-1

Features:

Published: Pre-2019

Delivery Format: Shipped

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63273545524BE3E50852576F6004A1B59
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/medical-affairs-excellence-services
18
19
20172.70.100.201
21
22
23721572.vil2cpkbu.asia
24/bestp/domrep.nsf
25SPCL